Jennison Associates’s Sanofi SNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-178,539
Closed -$8.65M 629
2025
Q4
$8.65M Sell
178,539
-10,146
-5% -$503K 0.01% 399
2025
Q3
$8.91M Buy
188,685
+3,812
+2% +$184K 0.01% 377
2025
Q2
$8.93M Buy
184,873
+16,770
+10% +$857K 0.01% 381
2025
Q1
$9.32M Sell
168,103
-32,135
-16% -$1.74M 0.01% 383
2024
Q4
$9.66M Sell
200,238
-1,704,207
-89% -$86.7M 0.01% 397
2024
Q3
$110M Buy
1,904,445
+1,720,972
+938% +$92.9M 0.07% 129
2024
Q2
$8.9M Sell
183,473
-6,149
-3% -$297K 0.01% 391
2024
Q1
$9.22M Buy
189,622
+30,115
+19% +$1.47M 0.01% 403
2023
Q4
$7.93M Buy
+159,507
New +$7.8M 0.01% 403
2014
Q1
Sell
-1,905,142
Closed -$102M 779
2013
Q4
$102M Buy
1,905,142
+355,785
+23% +$18.4M 0.1% 189
2013
Q3
$78.4M Sell
1,549,357
-4,671
-0.3% -$238K 0.08% 223
2013
Q2
$80M Buy
+1,554,028
New +$82.8M 0.09% 212

Other funds holding SNY

Jennison Associates's SNY Position: Q1 2026 in Review

Jennison Associates sold out of Sanofi (SNY) in Q1 2026, closing a stake of 178,539 shares — an estimated $8.65M sold.

Jennison Associates first reported a position in SNY in Q2 2013 and held it in 12 quarters. The position peaked at $110M in Q3 2024. 745 funds tracked by Wall St. Rank hold SNY as of Q1 2026.

  • Jennison Associates reported no remaining Sanofi position as of Q1 2026 after selling out during the quarter.
  • Jennison Associates sold 178,539 Sanofi shares in Q1 2026, an estimated $8.65M.
  • Jennison Associates first reported a position in Sanofi in Q2 2013 and held it in 12 quarters.
  • Jennison Associates's Sanofi position peaked at $110M in Q3 2024.
  • 745 funds tracked by Wall St. Rank held Sanofi as of Q1 2026.

Based on Jennison Associates's 13F filing for Q1 2026, filed 6 May 2026.